Commonwealth of Pennsylvania, acting by PA DEP v. Monsanto Co., Solutia Inc. and Pharmacia LLC

CourtCommonwealth Court of Pennsylvania
DecidedDecember 30, 2021
Docket668 M.D. 2020
StatusPublished

This text of Commonwealth of Pennsylvania, acting by PA DEP v. Monsanto Co., Solutia Inc. and Pharmacia LLC (Commonwealth of Pennsylvania, acting by PA DEP v. Monsanto Co., Solutia Inc. and Pharmacia LLC) is published on Counsel Stack Legal Research, covering Commonwealth Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Commonwealth of Pennsylvania, acting by PA DEP v. Monsanto Co., Solutia Inc. and Pharmacia LLC, (Pa. Ct. App. 2021).

Opinion

IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Commonwealth of Pennsylvania, acting : by the Commonwealth of Pennsylvania : Department of Environmental : Protection and the Commonwealth of : Pennsylvania Department of : Conservation and Natural Resources, : and the Pennsylvania Fish and Boat : Commission, and the Pennsylvania : Game Commission, : Plaintiffs : : v. : : Monsanto Co., Solutia Inc., and : Pharmacia LLC, : No. 668 M.D. 2020 Defendants : Argued: October 20, 2021

BEFORE: HONORABLE P. KEVIN BROBSON, President Judge HONORABLE RENÉE COHN JUBELIRER, Judge HONORABLE PATRICIA A. McCULLOUGH, Judge HONORABLE ANNE E. COVEY, Judge HONORABLE MICHAEL H. WOJCIK, Judge HONORABLE CHRISTINE FIZZANO CANNON, Judge HONORABLE J. ANDREW CROMPTON, Judge

OPINION BY JUDGE COVEY FILED: December 30, 2021

Before this Court are Monsanto Co.’s (Monsanto), Solutia Inc.’s (Solutia), and Pharmacia LLC’s (Pharmacia) (collectively, Defendants) Preliminary Objections (POs) to the First Amended Complaint (Complaint) filed by the Commonwealth of Pennsylvania (Commonwealth), acting by and through the Commonwealth’s Department of Environmental Protection (DEP), Department of Conservation and Natural Resources (DCNR), Fish and Boat Commission (FBC), and Game Commission (GC) (collectively, Plaintiffs), filed in this Court’s original jurisdiction. After review, this Court sustains the POs in part and overrules them in part.

Background1 Solutia and Pharmacia have succeeded to the liabilities of predecessor Monsanto2 which, from 1929 to 1977, manufactured, marketed, sold, and distributed approximately 99% of the polychlorinated biphenyls (PCBs) used in the United States (U.S.) - often under the trade names Aroclor, Pydraul, and Turbinol.3 See

1 Because this matter is before this Court on POs, the facts recited are as represented in Plaintiffs’ Complaint. 2 Solutia is a wholly-owned subsidiary of Eastman Chemical Company. See Complaint ¶ 30. Pharmacia is a wholly-owned subsidiary of Pfizer, Inc., and is the successor to the original Monsanto Chemical Company (Old Monsanto). See Complaint ¶ 31. Hence, Defendants collectively refer to themselves in this litigation as Pharmacia. “Following a merger transaction that closed in 2018, Monsanto is a wholly-owned subsidiary of Bayer AG.” Complaint ¶ 29. “Old Monsanto operated an agricultural products business, a pharmaceutical and nutrition business, and a chemical products business.” Complaint ¶ 32. Now, Monsanto operates Old Monsanto’s agricultural products business, Solutia operates Old Monsanto’s chemical products business, and Pharmacia operates Old Monsanto’s pharmaceuticals business. See Complaint ¶¶ 33-41. “Although Solutia assumed and agreed to indemnify [Monsanto] for certain liabilities related to the chemical[] business, Defendants have also entered into agreements to share or apportion liabilities, and/or to indemnify one or more entities, for claims arising from Old Monsanto’s chemical business, including the manufacture and sale of [polychlorinated biphenyls].” Complaint ¶ 38. In conjunction with Solutia’s Chapter 11 Bankruptcy, “Solutia, Pharmacia, and [] Monsanto entered into several agreements under which Monsanto continues to manage and assume financial responsibility for certain tort litigation and environmental remediation related to the chemical[] business.” Complaint ¶ 39. In Monsanto’s last filing with the United States Securities and Exchange Commission before Bayer AG acquired it, Monsanto reported: “Monsanto has liabilities established for various product claims. With respect to certain of these proceedings, Monsanto has established a reserve [($277 million as of August 31, 2017,)] for the estimated liabilities.” Complaint ¶ 41. 3 “Monsanto sold its PCB products for a variety of uses, including household uses. PCBs were sold for use in paints, caulks, inks, dyes, lubricants, sealants, plasticizers, coolants, hydraulic fluids, fireproofing, and industrial electrical equipment such as capacitors and transformers, among other applications. Monsanto also manufactured and sold various products incorporating their PCB formulations.” Complaint ¶ 9; see also Complaint Exs. 14-15. Notably, Old Monsanto also manufactured Dichlorodiphenyltrichloroethane (DDT) (another now infamous chlorinated hydrocarbon similar to PCBs) and, as early as the 1940s, had 2 Complaint ¶¶ 1, 3-4, 47, Complaint Exs. 14-15. “PCBs are either oily liquids or solids, and are colorless to light yellow[, and t]hey have no known smell or taste.” Complaint ¶ 44. PCBs “are toxic and dangerous synthetic[4] organic chemical compounds” harmful to human and animal health, and the environment. Complaint ¶¶ 1, 3; see also Complaint ¶ 42, Complaint Exs. 1-13, 16-19. “PCBs do not burn easily, are hydrophobic (i.e., they do not dissolve in water but rather cluster together), and bio-accumulate and bio-magnify in living tissue.” Complaint ¶ 48. Monsanto “acknowledged as early as 1937 that PCBs produce systemic toxic effects upon prolonged exposure.” Complaint ¶ 3; see also Complaint Exs. 1- 13, 16-19. In the 1950s, Monsanto’s medical director declared: “[W]e know Aroclors are toxic[,]” and advised workers not to eat lunch in Monsanto’s PCB department. Complaint Ex. 4; see also Complaint ¶ 3, Complaint Ex. 5. Due to PCBs’ proven toxicity and environmental persistence, “production and, with limited exceptions, use of PCBs was prohibited in the [U.S.] in 1979, when the U.S. Environmental Protection Agency ([]EPA[]) promulgated final regulations banning PCBs under the Toxic Substances Control Act [of 1976] ([]TSCA[]), enacted by the U.S. Congress in 1976.”5 Complaint ¶ 2. Despite that Monsanto knew early on of dangers associated with PCBs, and/or knew or should have known that PCBs “substantially persist in the natural environment rather than break down over time[,]” Complaint ¶ 7; that they “would

researched and was aware that DDT was extremely toxic to human and environmental health. See Complaint ¶¶ 102-108, 121. 4 There are no known natural sources of PCBs. See Complaint ¶¶ 1, 43. 5 15 U.S.C. § 2601-2697. Section 2605(e)(3)(A)(i) of the TSCA declares: “[N]o person may manufacture any [PCB] after two years after January 1, 1977[.]” 15 U.S.C. § 2605(e)(3)(A)(i); see also Dep’t of Gen. Servs. v. U.S. Min. Prods. Co., 927 A.2d 717, 721 n.2 (Pa. Cmwlth. 2007), aff’d, 956 A.2d 967 (Pa. 2008) (“The [TSCA] banned PCB manufacturing in the United States.”).

3 inevitably volatilize and leach, leak, and escape their intended applications, contaminating runoff during naturally occurring storm and rain events and entering groundwater, waterways, waterbodies, and other waters, sediment, soils, and plants, as well as fish and other wildlife[,]” Complaint ¶ 6; and “that PCBs bio-accumulate and bio-magnify in animal tissue, including in fish tissue and human tissue[, and] . . . pose[] an increasingly hazardous threat to the health of the Commonwealth’s residents[,]” Complaint ¶ 8; see also Complaint ¶ 48, Monsanto nevertheless continued to market and sell its products containing PCBs. See Complaint ¶¶ 9-10, 91-115. In September 1969, Monsanto formed an Aroclor Ad Hoc Committee, the minutes of which reflect: “[W]hile ‘there is no practical course of action that can so effectively police the uses of these products as to prevent environmental contamination . . . [t]here are . . . a number of actions which must be undertaken to prolong the manufacture, sale and use of these particular Aroclors as well as to protect the continued use of other members of the Aroclor series.’” Complaint ¶ 117 (quoting Complaint Ex. 10); see also Complaint ¶¶ 112-130.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Missouri v. Illinois & the Sanitary District
180 U.S. 208 (Supreme Court, 1900)
Georgia v. Tennesssee Copper Co.
206 U.S. 230 (Supreme Court, 1907)
Toomer v. Witsell
334 U.S. 385 (Supreme Court, 1948)
Ahrens v. Ford Motor Company
340 F.3d 1142 (Tenth Circuit, 2003)
State of New Mexico v. General Electric
467 F.3d 1223 (Tenth Circuit, 2006)
Berrier v. Simplicity Manufacturing, Inc.
563 F.3d 38 (Third Circuit, 2009)
Hoven v. Kelble
256 N.W.2d 379 (Wisconsin Supreme Court, 1977)
Piccolini v. Simon's Wrecking
686 F. Supp. 1063 (M.D. Pennsylvania, 1988)
Diess v. Pennsylvania Department of Transportation
935 A.2d 895 (Commonwealth Court of Pennsylvania, 2007)
James Corp. v. North Allegheny School District
938 A.2d 474 (Commonwealth Court of Pennsylvania, 2007)
Everhart v. PMA Insurance Group
938 A.2d 301 (Supreme Court of Pennsylvania, 2007)
MacHipongo Land and Coal Co., Inc. v. Com.
799 A.2d 751 (Supreme Court of Pennsylvania, 2002)
Commonwealth Ex Rel. Pappert v. TAP Pharmaceutical Products, Inc.
885 A.2d 1127 (Commonwealth Court of Pennsylvania, 2005)
Cafazzo v. Central Medical Health Services, Inc.
668 A.2d 521 (Supreme Court of Pennsylvania, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
Commonwealth of Pennsylvania, acting by PA DEP v. Monsanto Co., Solutia Inc. and Pharmacia LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/commonwealth-of-pennsylvania-acting-by-pa-dep-v-monsanto-co-solutia-pacommwct-2021.